EMERGING THERAPIES IN PSYCHEDELIC SCIENCE
1st Italian Conference on the clinical use of psychedelic substances
A conference that aims to present and discuss the latest available evidence on
the clinical applications of psychedelic substances.
Illustrate Artist: Anna Formilan
When & Where is it going to be?
Venues:
Teatro Zandonai, Palazzo Piomarta
Corso Angelo, Corso Bettini, 84,
38068 Rovereto TN, Italia
Link: https://www.teatro-zandonai.it/
Registration and ticket information
Secure your spot today and be part of the conversation shaping the future of psychedelic therapy.
The workshop fees are as follows:
140 € for faculty members and non academic participants.
35 € for Students and PhD students
50 € for online streaming
The cost of the Social Dinner is € 50.00 per person and is not included in the registration fees.
Confirmed speakers
Ornella Corazza
Chair of Addiction Science at the University of Hertfordshire and Director of a new Addiction Science Lab at the University of Trento
Gianluca Esposito
Professor at the University of Trento, Italy, and Co-Founder of the Addiction Science Lab
Matthias E. Liechti
Head of the Clinical Pharmacology Division and a professor for clinical pharmacology and internal medicine at the University Hospital Basel
David Erritzoe
Clinical Senior Lectureship in General Psychiatry in the Centres for Neuropsychopharmacology and Psychedelic Research at Imperial College London and CNWL Mental Health NHS Foundation Trust.
Kim PC Kuypers
Maastricht University, Faculty of Psychology and Neuroscience, Department of Neuropsychology and Psychopharmacology
Rick Doblin
Founder and President of the Multidisciplinary Association for Psychedelic Studies (MAPS)
Gabriele Penazzi
Addiction psychologist and former psychotherapist specializing in Gestalt therapy
Mauro D’Alonzo
Co-founder and President of SIMEPSI (Italian Society of Psychedelic Medicine)
Marco Perduca
Board of No Peace Without Justice Luca Coscioni Association
Michèle Anne Barocchi
Co-founder and executive director of MAPS Italia
Tania Re
Gestalt psychotherapist, clinical and community psychologist, Naturopathic Doctor,
Marion Haberkamp
Head of Unit Neurology, Psychiatry, Ophthalmology, Federal Institute for Drugs and Medical Devices, Germany
Tadeusz Hawrot
Founder and Executive Director, Psychedelic Access and Research European Alliance
Dr. Matteo Buonarroti
General practitioner currently specializing in psychiatry and psychotherapy
Benyamina Amine
Addiction psychiatrist at the Paul Brousse University Hospital in Villejuif, France
Tommaso Barba
PhD candidate at the Centre for Psychedelic Research, Imperial College, London
What can you expect from this Conference?
Benefits to Society
Exploring how such substances can be used to benefit society and improve lives.
Subjective Experiences
Providing a better understanding of the subjective experiences with psychedelics.
Understanding Mechanims
Understanding the mechanisms underpinning the effects of psychedelics;
Fostering Collaborations
Encouraging collaborations among early careers reseaercehrs and budding scientists.
Multidisciplinary Teams
Strengthening collaborations and exchange of ideas between multidiscipliunary teams.
Promoting Awareness
Promoting knowledge and awareness about psychedelics’ use in clinical settings.
Join us in this pioneering event that promises to be as educational as it is inspiring!
Whether you are a researcher, a healthcare professional, or an enthusiast eager to learn more about the clinical potential of psychedelics, this conference will offer valuable insights and opportunities to connect with leading experts in the field. Looking forward to see you there.
Reserve your seat now as places are limited!
Secure your place today and be part of this exceptional convergence of science and society!
Who are the people behind it?
Organising Committee
Professor Ornella Corazza, Director, Addiction Science Lab, University of Trento (Italy)
Professor Nicola de Pisapia, Addiction Science Lab, University of Trento (Italy)
Professor Gianluca Esposito, Addiction Science Lab, University of Trento (Italy)
Professor Jeroen Vaes, University of Trento (Italy)
Sandra Iob, University of Trento (Italy)
Samantha Pedrana, University of Trento (Italy)
Maria Lunardi, University of Trento (Italy)
Dr. Sofia Venturini, Addiction Lab,University of Trento(Italy)
Prof. Maria Micaela Coppola, University of Trento (Italy)
Diletta Cecchi, MAPS Italia rappresentative
Michelle Barocchi, MAPS Italia rappresentative
Marco Perduca, MAPS Italia rappresentative
Federico Menapace, MAPS rappresentative
Dr. Ermelinda Levari, U.O. Dipendenze, APSS, Trento (Italy)
Michèle Anne Barocchi, MAPS Italia
Scientific Committee
Professor Ornella Corazza, Director | Addiction Science Lab, University of Trento (Italy)
Professor Nicola de Pisapia, Addiction Science Lab, University of Trento (Italy)
Professor Gianluca Esposito, Addiction Science Lab, University of Trento (Italy)